Related references
Note: Only part of the references are listed.Efficient gene silencing by delivery of locked nucleic acid antisense oligonucleotides, unassisted by transfection reagents
C. A. Stein et al.
NUCLEIC ACIDS RESEARCH (2010)
Down-Modulation of Survivin Expression and Inhibition of Tumor Growth In Vivo by EZN-3042, A Locked Nucleic Acid Antisense Oligonucleotide
Puja Sapra et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2010)
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
David T. Teachey et al.
BLOOD (2008)
First human dose study evaluating safety and pharmacokinetics of LY2181308, an antisense oligonucleotide designed to inhibit survivin
D. C. Talbot et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I and Pharmacokinetic Study of YM155, a Small-Molecule Inhibitor of Survivin
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
SPC3042:: a proapoptotic survivin inhibitor
Jens Bo Hansen et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Inhibition of the Akt/survivin pathway synergizes the antileukernia effect of nutlin-3 in acute lymphoblastic leukemia cells
Ningxi Zhu et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Interplay among BRCA1, SIRT1, and Survivin during BRCA1-Associated Tumorigenesis
Rui-Hong Wang et al.
MOLECULAR CELL (2008)
Terminally differentiated neutrophils predominantly express survivin-2α, a dominant-negative isoform of survivin
Huiyuan Hu et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2008)
A functional Notch-survivin gene signature in basal breast cancer
Connie W. Lee et al.
BREAST CANCER RESEARCH (2008)
Opinion - Survivin, cancer networks and pathway-directed drug discovery
Dario C. Altieri
NATURE REVIEWS CANCER (2008)
The role of survivin for radiation therapy -: Prognostic and predictive factor and therapeutic target
Gianni Capalbo et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2007)
Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer
Anne B. Als et al.
CLINICAL CANCER RESEARCH (2007)
Targeting survivin in cancer therapy: fulfilled promises and open questions
Marzia Pennati et al.
CARCINOGENESIS (2007)
Regulation of survivin expression by IGF-1/mTOR signaling
V. Vaira et al.
ONCOGENE (2007)
Dynamic intracellular survivin in oral squamous cell carcinoma:: underlying molecular mechanism and potential as an early prognostic marker
K. Engels et al.
JOURNAL OF PATHOLOGY (2007)
Survivin subcellular localization in high-grade astrocytomas: simultaneous expression in both nucleus and cytoplasm is negative prognostic marker
Taiichi Saito et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy
R. Kim et al.
CANCER GENE THERAPY (2007)
Diverse pathways mediate chemotherapy-induced cell death in acute lymphoblastic leukemia cell lines
Dong-Joon Min et al.
APOPTOSIS (2006)
Biologic pathways associated with relapse in childhood acute lymphoblastic leukemia: a Children's Oncology Group study
Deepa Bhojwani et al.
BLOOD (2006)
Tliptolide induces caspase-dependent cell death mediated via the mitochondfial pathway in leukemic cells
Bing Z. Carter et al.
BLOOD (2006)
Survivin stable knockdown by siRNA inhibits tumor cell growth and angiogenesis in breast and cervical cancers
Qing-Xia Li et al.
CANCER BIOLOGY & THERAPY (2006)
Survivin: An inhibitor of apoptosis in pediatric cancer
Jason R. Fangusaro et al.
PEDIATRIC BLOOD & CANCER (2006)
Survivin, a cancer target with an emerging role in normal adult tissues
Seiji Fukuda et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells
E Tirrò et al.
CANCER RESEARCH (2006)
Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin
K Yonesaka et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Adenoviral infection of survivin antisense sensitizes prostate cancer cells to etoposide in vivo
N Hayashi et al.
PROSTATE (2005)
Expression of survivin and of antigen detected by a novel monoclonal antibody, T332, is associated with outcome of diffuse large B-cell lymphoma and its subtypes
R Watanuki-Miyauchi et al.
PATHOLOGY INTERNATIONAL (2005)
Induction of survivin expression by taxol (paclitaxel) is an early event, which is independent of taxol-mediated G2/M arrest
X Ling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
S Paik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
High expression levels of X-linked inhibitor of apoptosis protein and survivin correlate with poor overall survival in childhood de Novo acute myeloid leukemia
I Tamm et al.
CLINICAL CANCER RESEARCH (2004)
Regulation of survivin function by Hsp90
P Fortugno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells
MX Zhou et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes
M Hattori et al.
CANCER LETTERS (2001)
Urine detection of survivin and diagnosis of bladder cancer
SD Smith et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
The Survivin : Fas ratio in pediatric renal tumors
S Takamizawa et al.
JOURNAL OF PEDIATRIC SURGERY (2001)
High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma
A Islam et al.
ONCOGENE (2000)
Share Paper
